![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: B3GNT4 |
Gene summary for B3GNT4 |
![]() |
Gene information | Species | Human | Gene symbol | B3GNT4 | Gene ID | 79369 |
Gene name | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 | |
Gene Alias | B3GN-T4 | |
Cytomap | 12q24.31 | |
Gene Type | protein-coding | GO ID | GO:0000271 | UniProtAcc | Q9C0J1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
79369 | B3GNT4 | P80T-E | Human | Esophagus | ESCC | 1.30e-10 | 3.06e-01 | 0.155 |
79369 | B3GNT4 | P82T-E | Human | Esophagus | ESCC | 4.14e-03 | 1.62e-01 | 0.1072 |
79369 | B3GNT4 | P83T-E | Human | Esophagus | ESCC | 2.18e-11 | 3.18e-01 | 0.1738 |
79369 | B3GNT4 | P89T-E | Human | Esophagus | ESCC | 6.02e-08 | 4.97e-01 | 0.1752 |
79369 | B3GNT4 | P91T-E | Human | Esophagus | ESCC | 1.76e-08 | 5.09e-01 | 0.1828 |
79369 | B3GNT4 | P107T-E | Human | Esophagus | ESCC | 1.46e-08 | 1.93e-01 | 0.171 |
79369 | B3GNT4 | P130T-E | Human | Esophagus | ESCC | 1.02e-31 | 5.56e-01 | 0.1676 |
Page: 1 2 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![]() | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias | ||
LGIN: Low-grade intraepithelial neoplasias |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00091002 | Esophagus | ESCC | glycoprotein metabolic process | 226/8552 | 387/18723 | 2.64e-07 | 3.94e-06 | 226 |
GO:00067906 | Esophagus | ESCC | sulfur compound metabolic process | 201/8552 | 339/18723 | 2.64e-07 | 3.94e-06 | 201 |
GO:00442725 | Esophagus | ESCC | sulfur compound biosynthetic process | 96/8552 | 148/18723 | 1.86e-06 | 2.16e-05 | 96 |
GO:00700854 | Esophagus | ESCC | glycosylation | 144/8552 | 240/18723 | 5.12e-06 | 5.38e-05 | 144 |
GO:00064865 | Esophagus | ESCC | protein glycosylation | 135/8552 | 226/18723 | 1.36e-05 | 1.24e-04 | 135 |
GO:00434135 | Esophagus | ESCC | macromolecule glycosylation | 135/8552 | 226/18723 | 1.36e-05 | 1.24e-04 | 135 |
GO:00091012 | Esophagus | ESCC | glycoprotein biosynthetic process | 181/8552 | 317/18723 | 2.54e-05 | 2.15e-04 | 181 |
GO:00442626 | Esophagus | ESCC | cellular carbohydrate metabolic process | 160/8552 | 283/18723 | 1.43e-04 | 9.66e-04 | 160 |
GO:00160514 | Esophagus | ESCC | carbohydrate biosynthetic process | 117/8552 | 202/18723 | 2.96e-04 | 1.79e-03 | 117 |
GO:00064931 | Esophagus | ESCC | protein O-linked glycosylation | 51/8552 | 86/18723 | 7.54e-03 | 2.70e-02 | 51 |
GO:0006024 | Esophagus | ESCC | glycosaminoglycan biosynthetic process | 45/8552 | 75/18723 | 8.75e-03 | 3.08e-02 | 45 |
GO:0006023 | Esophagus | ESCC | aminoglycan biosynthetic process | 47/8552 | 79/18723 | 9.29e-03 | 3.23e-02 | 47 |
GO:00346372 | Esophagus | ESCC | cellular carbohydrate biosynthetic process | 46/8552 | 78/18723 | 1.24e-02 | 4.13e-02 | 46 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
B3GNT4 | SNV | Missense_Mutation | c.288N>G | p.Phe96Leu | p.F96L | Q9C0J1 | protein_coding | deleterious(0.04) | possibly_damaging(0.541) | TCGA-A2-A0D0-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD | |
B3GNT4 | SNV | Missense_Mutation | rs147517845 | c.869N>A | p.Arg290His | p.R290H | Q9C0J1 | protein_coding | tolerated(0.22) | benign(0.019) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
B3GNT4 | SNV | Missense_Mutation | novel | c.7C>T | p.Pro3Ser | p.P3S | Q9C0J1 | protein_coding | deleterious_low_confidence(0) | benign(0.044) | TCGA-BH-A0H5-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | CR |
B3GNT4 | SNV | Missense_Mutation | c.1045N>T | p.His349Tyr | p.H349Y | Q9C0J1 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-C8-A12T-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
B3GNT4 | SNV | Missense_Mutation | novel | c.539N>G | p.Asp180Gly | p.D180G | Q9C0J1 | protein_coding | deleterious(0) | possibly_damaging(0.862) | TCGA-D8-A1Y1-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | tamoxiphen | PD |
B3GNT4 | deletion | Frame_Shift_Del | c.243_244delNN | p.Ser83Ter | p.S83* | Q9C0J1 | protein_coding | TCGA-E2-A15D-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | |||
B3GNT4 | SNV | Missense_Mutation | rs147517845 | c.869N>A | p.Arg290His | p.R290H | Q9C0J1 | protein_coding | tolerated(0.22) | benign(0.019) | TCGA-A6-2672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
B3GNT4 | SNV | Missense_Mutation | rs150666707 | c.221G>A | p.Ser74Asn | p.S74N | Q9C0J1 | protein_coding | tolerated(0.09) | benign(0.003) | TCGA-AA-3947-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
B3GNT4 | SNV | Missense_Mutation | rs749136382 | c.253G>A | p.Ala85Thr | p.A85T | Q9C0J1 | protein_coding | tolerated(0.79) | benign(0.005) | TCGA-AD-6889-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | xeloda | PD |
B3GNT4 | SNV | Missense_Mutation | rs570110830 | c.868N>T | p.Arg290Cys | p.R290C | Q9C0J1 | protein_coding | deleterious(0.01) | benign(0.052) | TCGA-AZ-6601-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |